• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ipilimumab-associated Sweet syndrome in a patient with high-risk melanoma.

作者信息

Kyllo Rachel L, Parker Mary Kendall, Rosman Ilana, Musiek Amy C

机构信息

Washington University School of Medicine, St Louis, Missouri.

Division of Dermatology, Washington University, St Louis, Missouri.

出版信息

J Am Acad Dermatol. 2014 Apr;70(4):e85-e86. doi: 10.1016/j.jaad.2013.11.022.

DOI:10.1016/j.jaad.2013.11.022
PMID:24629370
Abstract
摘要

相似文献

1
Ipilimumab-associated Sweet syndrome in a patient with high-risk melanoma.一名高危黑色素瘤患者出现的与伊匹单抗相关的Sweet综合征。
J Am Acad Dermatol. 2014 Apr;70(4):e85-e86. doi: 10.1016/j.jaad.2013.11.022.
2
Myasthenia Gravis Induced by Ipilimumab in Patients With Metastatic Melanoma.伊匹单抗诱发转移性黑色素瘤患者发生重症肌无力
J Clin Oncol. 2015 Nov 20;33(33):e122-4. doi: 10.1200/JCO.2013.51.1683. Epub 2014 Apr 28.
3
Sweet syndrome associated with ipilimumab in a patient with metastatic melanoma.一名转移性黑色素瘤患者中与伊匹单抗相关的Sweet综合征。
Clin Exp Dermatol. 2018 Jun;43(4):497-499. doi: 10.1111/ced.13399. Epub 2018 Feb 3.
4
Ipilimumab-associated Sweet syndrome in a melanoma patient.一名黑色素瘤患者出现的与伊匹单抗相关的Sweet综合征。
J Am Acad Dermatol. 2014 Nov;71(5):e211-3. doi: 10.1016/j.jaad.2014.06.042. Epub 2014 Oct 15.
5
Lymphocytic vasculitis of the uterus in a patient with melanoma receiving ipilimumab.一名接受伊匹单抗治疗的黑色素瘤患者发生子宫淋巴细胞性血管炎。
J Clin Oncol. 2013 Jul 10;31(20):e356. doi: 10.1200/JCO.2012.47.5095. Epub 2013 Jun 3.
6
Sweet's syndrome under ipilimumab therapy and a brief comparison of the cases in literature.伊匹单抗治疗下的Sweet综合征及文献中病例的简要比较。
J Oncol Pharm Pract. 2020 Oct;26(7):1762-1764. doi: 10.1177/1078155220906885. Epub 2020 Feb 23.
7
Sweet's syndrome in a patient with metastatic melanoma after ipilimumab therapy.伊匹单抗治疗后转移性黑色素瘤患者的Sweet 综合征。
Melanoma Res. 2013 Dec;23(6):498-501. doi: 10.1097/CMR.0000000000000017.
8
Drug-Induced Sweet Syndrome in a Man With Sarcoidosis: Are There Any Common Mechanisms of Pathogenesis?结节病男性患者的药物性Sweet综合征：是否存在共同的发病机制？
J Clin Rheumatol. 2019 Oct;25(7):e122-e126. doi: 10.1097/RHU.0000000000000730.
9
Azacitidine-induced Sweet syndrome: Two unusual clinical presentations.阿扎胞苷诱发的Sweet综合征：两种不寻常的临床表现。
Australas J Dermatol. 2018 Aug;59(3):e224-e225. doi: 10.1111/ajd.12727. Epub 2017 Oct 18.
10
Xanthomatized Neutrophilic Dermatosis in a Patient With Myelodysplastic Syndrome.骨髓增生异常综合征患者的黄瘤样嗜中性皮病
Am J Dermatopathol. 2017 May;39(5):384-387. doi: 10.1097/DAD.0000000000000774.

引用本文的文献

1
Multiple Cutaneous Adverse Reactions Secondary to Nivolumab Therapy in an Elderly Male.一名老年男性接受纳武单抗治疗后出现的多种皮肤不良反应
Cureus. 2025 Mar 31;17(3):e81542. doi: 10.7759/cureus.81542. eCollection 2025 Mar.
2
Approach to the Atypical Wound.非典型创面处理方法。
Am J Clin Dermatol. 2024 Jul;25(4):559-584. doi: 10.1007/s40257-024-00865-0. Epub 2024 May 14.
3
Giant Cellulitis-Like Sweet Syndrome Masquerading As Cellulitis and Shingles: A Case Report and Literature Review.伪装成蜂窝织炎和带状疱疹的巨细胞性蜂窝织炎样斯威特综合征：一例报告及文献综述
Cureus. 2023 Mar 16;15(3):e36232. doi: 10.7759/cureus.36232. eCollection 2023 Mar.
4
Immune-Related Uncommon Adverse Events in Patients with Cancer Treated with Immunotherapy.接受免疫治疗的癌症患者中与免疫相关的罕见不良事件
Diagnostics (Basel). 2022 Aug 29;12(9):2091. doi: 10.3390/diagnostics12092091.
5
Aseptic Abscess Syndrome: Clinical Characteristics, Associated Diseases, and up to 30 Years' Evolution Data on a 71-Patient Series.无菌性脓肿综合征：71例患者系列的临床特征、相关疾病及长达30年的演变数据
J Clin Med. 2022 Jun 25;11(13):3669. doi: 10.3390/jcm11133669.
6
Drug eruptions with novel targeted therapies - immune checkpoint and EGFR inhibitors.新型靶向治疗药物的皮肤不良反应——免疫检查点抑制剂和 EGFR 抑制剂。
J Dtsch Dermatol Ges. 2021 Nov;19(11):1621-1643. doi: 10.1111/ddg.14641.
7
"Skin rashes" and immunotherapy in melanoma: distinct dermatologic adverse events and implications for therapeutic management.“皮肤皮疹”与黑色素瘤的免疫治疗：不同的皮肤不良反应及其对治疗管理的影响。
Hum Vaccin Immunother. 2022 May 31;18(3):1889449. doi: 10.1080/21645515.2021.1889449. Epub 2021 Mar 24.
8
Dermatologic toxicities to immune checkpoint inhibitor therapy: A review of histopathologic features.免疫检查点抑制剂治疗的皮肤毒性：组织病理学特征综述。
J Am Acad Dermatol. 2020 Oct;83(4):1130-1143. doi: 10.1016/j.jaad.2020.04.105. Epub 2020 Apr 29.
9
Active repurposing of drug candidates for melanoma based on GWAS, PheWAS and a wide range of omics data.基于 GWAS、PheWAS 和广泛的组学数据对候选药物进行主动再利用以治疗黑色素瘤。
Mol Med. 2019 Jun 20;25(1):30. doi: 10.1186/s10020-019-0098-x.
10
Insights Into the Pathogenesis of Sweet's Syndrome.Sweet 综合征发病机制的研究进展。
Front Immunol. 2019 Mar 12;10:414. doi: 10.3389/fimmu.2019.00414. eCollection 2019.